A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)

Condition:   Paget's Disease of BoneIntervention:   Drug: alendronateSponsor:   Merck Sharp & Dohme Corp.Completed - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials